glp-1 receptor agonist and dpp-4 inhibitor combination not recommended The Role of Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect Frontiers | Mechanisms of action
Description
Patient-specific factors including age, comorbidities, and ability to implement lifestyle modifications significantly influence appropriate treatment duration
Glucagon-like refers to the fact that the structure of GLP-1 resembles that of glucagon, a hormone involved in regulating blood sugar
Abrupt discontinuation followed by immediate full-dose initiation of a new medication increases side effect risk and may cause a temporary rebound in appetite and weight
Children: The recommended maintenance dose is 3 mg once daily
Today they stand on the threshold of helping with chronic inflammation
